The spine bone stimulators market is expected to grow through 2022 as osteoporosis and arthritis become increasingly prevalent, according to a Research and Markets report.
Here are four things to know:
1. The market is projected to grow at a compound annual growth rate of 3.6 percent, increasing its value from the $562 million it was worth in 2015 to $724 million by 2022.
2. Market drivers are expected to include the increase in geriatric population and the rise of osteoporosis and arthritis.
3. Market impeders may be the high initial cost of stimulators as well as the advent of bone growth-stimulating drugs, fixation instrumentation during fusion and non-fusion fractures.
4. Bone stimulators deliver low-voltage electrical currents to the spinal area where spine fusion is expected to occur.
More articles on devices:
Baxter highlights FLOSEAL hemostatic agent enhancements for spine, cardiac surgery: 5 highlights
Implanet intends to transfer share listing from Euronext to Alternext Paris: 5 key notes